Cited by 137RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryAdvancements in Transdermal Drug Delivery

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages

Yu, Wangyang, Liu, Chunxi, Liu, Yu, Zhang, Na, Xu, Wenfang·2010·Pharmaceutical Research

Open this paper in CoChat — free account

Abstract

Purpose Cationic solid lipid nanoparticles (SLN) have established themselves during the past decades. They can efficiently bind DNA directly via ionic interaction and mediate gene transfection. One major problem with SLN is the lack of cell-targeting ability. In the present study, a mannan-based PE-grafted ligand was synthesized and used for the surface modification of DNA-loaded cationic SLN to prepare Man-SLN-DNA.Methods For in vitro test, the cytotoxicity and transfection investigation was carried out on murine macrophage cell line RAW 264.7. For in vivo evaluation, Man-SLN-DNA was delivered into the lung of the rats, and the alveolar macrophages (AM) were isolated for the fluorescence determination of transfection efficiency.Results When compared with non-modified SLN-DNA and Lipofectamine 2000-DNA, Man-SLN-DNA produced the highest gene expressions, especially in vivo.Conclusion These results demonstrated the active targeting ability of this kind of mannan-modified DNA-loaded vehicles, which may have great potential for targeted gene delivery.

Integrity signals

Registry

Crossref · 10.1007/s11095-010-0149-z

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,483
Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
Jemal, A., Thun, M. J., Ries, L. A. G., Howe, H. L., Weir, H. K., Ward, E., Wu, X., Eheman, C. R., Anderson, R. N., Ajani, U. A., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn389 · Cited by 961
Role of tumor-associated macrophages in tumor progression and invasion
Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9001-7 · Cited by 901
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoît, J. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.036 · Cited by 786
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
Torchilin, V. P. (2007) · The AAPS Journal · doi:10.1208/aapsj0902015 · Cited by 771
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
van Vlerken, L. E., Vyas, T. K., & Amiji, M. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9284-6 · Cited by 646
Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor
Ezekowitz, R. A. B., Williams, D., Koziel, H., Armstrong, M. Y. K., Warner, A., Richards, F. F., & Rose, R. M. (1991) · Nature · doi:10.1038/351155a0 · Cited by 447
Targeted delivery of nanoparticles for the treatment of lung diseases
Azarmi, S., Roa, W. H., & Löbenberg, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.006 · Cited by 440
Active targeting of brain tumors using nanocarriers
Béduneau, A., Saulnier, P., & Benoît, J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.011 · Cited by 433
Clinical toxicities of nanocarrier systems.
Vega-Villa, K. R., Takemoto, J. K., Yáñez, J. A., Remsberg, C. M., Forrest, M. L., & Davies, N. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.007 · Cited by 325

Show all 39 references

Research works printed but not linked: 1

Wijagkanalan W, Kawakami S, Takenaga M, Igarashi R, Yamashita F, Hashida M. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release. 2008;125:121–30. · DOI

Sorted by citations

Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,475
Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia
Song, M., Liu, T., Shi, C., Zhang, X., & Chen, X. S. (2015) · ACS Nano · doi:10.1021/acsnano.5b06779 · Cited by 665
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – A systematic review of in vitro data
Doktorovová, S., Souto, E. B., & Silva, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.005 · Cited by 419
Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies
Geszke-Moritz, M., & Moritz, M. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.05.119 · Cited by 393
Harnessing innate immune pathways for therapeutic advancement in cancer
Hu, A.-K., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. Q. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 286
Targeting of Tumor-Associated Macrophages Made Possible by PEG-Sheddable, Mannose-Modified Nanoparticles
Zhu, S., Niu, M., O’Mary, H. L., & Cui, Z. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400216r · Cited by 233
Hypoxic tumor microenvironment: Opportunities to develop targeted therapies
Patel, A., & Sant, S. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.04.005 · Cited by 205
An Overview of Methods and Tools for Transfection of Eukaryotic Cells in vitro
Fus-Kujawa, A., Prus, P., Bajdak-Rusinek, K., Teper, P., Gawron, K., Kowalczuk, A., & Sieroń, A. L. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.701031 · Cited by 213
Targeted depletion of tumour-associated macrophages by an alendronate–glucomannan conjugate for cancer immunotherapy
Zhan, X., Jia, L., Niu, Y., Qi, H., Chen, X., Zhang, Q., Zhang, J., Wang, Y., Dong, L., & Wang, C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.09.007 · Cited by 161
Nanoparticles-mediated drug delivery approaches for cancer targeting: a review
Sultana, S., Khan, M. R., Kumar, M., Kumar, S., & Ali, M. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.712130 · Cited by 152
High melting lipid based approach for drug delivery: Solid lipid nanoparticles
Kumar, S., & Randhawa, J. K. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.01.037 · Cited by 152
Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA
Shao, Z., Shao, J., Tan, B., Guan, S., Liu, Z., Zhao, Z., He, F., & Zhao, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77837 · Cited by 148
Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanisms
de Jesus, M. B., & Zuhorn, I. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.010 · Cited by 139
In Vivo Sustained Release of siRNA from Solid Lipid Nanoparticles
Lobovkina, T., Jacobson, G. B., González-González, E., Hickerson, R. P., Leake, D., Kaspar, R. L., Contag, C. H., & Zare, R. N. (2011) · ACS Nano · doi:10.1021/nn203745n · Cited by 139
The formulation of nanomedicines for treating tuberculosis
Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123
Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo
Li, K., Lu, L., Xue, C., Liu, J., He, Y., Zhou, J., Xia, Z., Dai, L., Luo, Z. Y., Mao, Y., et al. (2019) · Nanoscale · doi:10.1039/c9nr06505a · Cited by 113
Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy
Song, S., Mao, G., Du, J., & Zhu, X. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1064186 · Cited by 112
Nanomedicine Strategies to Target Tumor-Associated Macrophages
Binnemars‐Postma, K., Storm, G., & Prakash, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050979 · Cited by 112
Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases
Anderson, C. F., Grimmett, M. E., Domalewski, C. J., & Cui, H. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1586 · Cited by 112
Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems
Dolatabadi, J. E. N., & Omidi, Y. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.12.016 · Cited by 106
A Recent Update: Solid Lipid Nanoparticles for Effective Drug Delivery
Pandey, S. S., Shaikh, F. I., Gupta, A. R., Tripathi, P., & Yadav, J. S. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.007 · Cited by 113
Biodistribution and in Vivo Activities of Tumor-Associated Macrophage-Targeting Nanoparticles Incorporated with Doxorubicin
Niu, M., Naguib, Y. W., Aldayel, A. M., Shi, Y.-C., Hursting, S. D., Hersh, M. A., & Cui, Z. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500565q · Cited by 106
Absorption, Disposition and Pharmacokinetics of Solid Lipid Nanoparticles
Qi, J., Lü, Y., & Wu, W. (2012) · Current Drug Metabolism · doi:10.2174/138920012800166526 · Cited by 98
Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery
Wang, H., Lu, Q., Zhang, X., Guan, J., & Mao, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.061 · Cited by 90
Nanoparticles in Gene Therapy
Liu, C., & Zhang, N. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-416020-0.00013-9 · Cited by 90
Self-citation
Inhalable solid lipid nanoparticles for intracellular tuberculosis infection therapy: macrophage-targeting and pH-sensitive properties
Ma, C., Wu, M., Ye, W., Huang, Z., Ma, X., Wang, W., Wang, W., Huang, Y., Pan, X., & Wu, C. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00849-7 · Cited by 84
Novel Method to Label Solid Lipid Nanoparticles with 64Cu for Positron Emission Tomography Imaging
Andreozzi, E. M., Seo, J. W., Ferrara, K. W., & Louie, A. Y. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100478k · Cited by 80
Small Molecule–Gold Nanorod Conjugates Selectively Target and Induce Macrophage Cytotoxicity towards Breast Cancer Cells
Dreaden, E. C., Mwakwari, S. C., Austin, L. A., Kieffer, M. J., Oyelere, A. K., & El‐Sayed, M. A. (2012) · Small · doi:10.1002/smll.201200333 · Cited by 81
Lipid-based carriers: manufacturing and applications for pulmonary route
Jaafar‐Maalej, C., Elaı̈ssari, A., & Fessi, H. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.702751 · Cited by 77
Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin
Kong, F., Han, Y., Zhang, Y., Li, D., Chen, Y., & Sun, J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s67770 · Cited by 77
Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives
Torrecilla, J., Rodríguez‐Gascón, A., Solinís, M. Á., & del Pozo‐Rodríguez, A. (2014) · BioMed Research International · doi:10.1155/2014/161794 · Cited by 77
Biomaterials for in situ cell therapy
Wang, C., Wang, S., Kang, D. D., & Dong, Y. (2023) · BMEMat · doi:10.1002/bmm2.12039 · Cited by 74
Polysaccharide Nanoparticles for Protein and Peptide Delivery
dos Santos, M. A., & Grenha, A. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2014.11.003 · Cited by 73
Molecular and cellular cues governing nanomaterial–mucosae interactions: from nanomedicine to nanotoxicology
das Neves, J., Arzi, R. S., & Sosnik, A. (2020) · Chemical Society Reviews · doi:10.1039/c8cs00948a · Cited by 74
In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer
Zhang, N., Zhang, B., Gong, X., Wang, T., Liu, Y., & Yang, S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s104119 · Cited by 70
Self-citation
Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery
Zhang, B., Zhang, Y., & Yu, D. (2016) · Oncology Reports · doi:10.3892/or.2016.5298 · Cited by 69
Targeted Imaging of CD206 Expressing Tumor-Associated M2-like Macrophages Using Mannose-Conjugated Antibiofouling Magnetic Iron Oxide Nanoparticles
Li, Y., Wu, H. C., Ji, B., Qian, W., Xia, S., Wang, L., Xu, Y., Chen, J., Yang, L. P. H., & Mao, H. Z. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00368 · Cited by 69
Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy
Han, Y., Li, Y., Zhang, P., Sun, J., Li, X., Sun, X., & Kong, F. (2015) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.996900 · Cited by 66
Mannosylated liposomes for targeted gene delivery
Kong, F., Zhou, Ge, G., Liu, Wang, & Zhou (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29183 · Cited by 64
Nanostructured lipid carriers versus solid lipid nanoparticles for the potential treatment of pulmonary hypertension via nebulization
Nafee, N. A., Makled, S., & Boraie, N. A. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.10.003 · Cited by 62
Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood–Brain Barrier Transmitters
Amiri, M., Jafari, S., Kurd, M., Mohamadpour, H., Khayati, M., Ghobadinezhad, F., Tavallaei, O., Derakhshankhah, H., Malvajerd, S. S., & Izadi, Z. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00540 · Cited by 61
Advances in Pulmonary Delivery of Nanoparticles
Kaur, G., Narang, R. K., Rath, G., & Goyal, A. K. (2011) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.3109/10731199.2011.592494 · Cited by 60
Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles
Bian, Y., & Guo, D. Y. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s238955 · Cited by 59
Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice
Valetti, S., Mura, S., Stella, B., & Couvreur, P. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-s1-s6 · Cited by 55
Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment
Yu, D., Li, W., Zhang, Y., & Zhang, B. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.061 · Cited by 52
Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection
Kong, F., Wang, Zhou, Ge, G., & Liu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31915 · Cited by 49
Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano–bio interactions
Zhang, M., Lu, H., Xie, L., Liu, X., Cun, D., & Yang, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115144 · Cited by 50
Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers
Rawal, S. U., & Patel, M. M. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00630-6 · Cited by 46
A state-of-the-art review on solid lipid nanoparticles as a nanovaccines delivery system
Assefi, M., Ataeinaeini, M., Nazari, A., Gholipour, A., Vértiz-Osores, J. J., Vásquez, K. M. C., Al-Naqeeb, B. Z. T., Jassim, K. H., Kalajahi, H. G., Yasamineh, S., et al. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104623 · Cited by 44
Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery Applications
Alwani, S., Wasan, E. K., & Badea, I. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00128 · Cited by 43
A novel cationic liposome formulation for efficient gene delivery via a pulmonary route
Li, P., Liu, D., Sun, X., Liu, C., Liu, Y., & Zhang, N. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/24/245104 · Cited by 43
Self-citation
Nanocarriers for spleen targeting: anatomo-physiological considerations, formulation strategies and therapeutic potential
Jindal, A. B. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0304-0 · Cited by 42
Lipid nanoparticulate systems
Rawal, S. U., & Patel, M. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813687-4.00002-5 · Cited by 42
Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid–polymer hybrid nanoparticles
Fu, Q., Wang, J., & Liu, H. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1837294 · Cited by 42
Nano-mediated strategy for targeting and treatment of non-small cell lung cancer (NSCLC)
Ashique, S., Garg, A., Mishra, N., Raina, N., Ming, L. C., Tuli, H. S., Behl, T., Rani, R., & Gupta, M. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02522-5 · Cited by 36
TAT modified and lipid – PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA
Dong, S., Zhou, X., & Yang, J. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.003 · Cited by 35
Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer
Wang, Z., Zang, A., Wei, Y., An, L. K., Hong, D., Shi, Y., Zhang, J., Su, S., & Fang, G. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s230306 · Cited by 35
Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers
Bao, H., Zheng, N., Li, Z., & Zhi, Y. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s256636 · Cited by 35
Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers?
Du, J., & Li, L. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1099058 · Cited by 35
Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers
Wang, Z., Wei, Y., Fang, G., Hong, D., An, L. K., Jiao, T., Shi, Y., & Zang, A. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s175614 · Cited by 33
Comparative Analysis of Mannans Extraction Processes from Spent Yeast Saccharomyces cerevisiae
Faustino, M., Durão, J., Pereira, C. F., Oliveira, A. S., Pereira, J. O., Pereira, A. M., Ferreira, C., Pintado, M., & CARVALHO, A. P. F. D. (2022) · Foods · doi:10.3390/foods11233753 · Cited by 33
Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer
Chen, Y., Xu, Z., Lu, T., Luo, J., & Xue, H. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2110998 · Cited by 32
Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy
Kang, X., Huang, Y., Wang, H., Jadhav, S., Yue, Z., Tiwari, A. K., & Babu, R. J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010061 · Cited by 35
Dual ligands modified double targeted nano-system for liver targeted gene delivery
Jing, F., Li, J., Liu, D., Wang, C., & Sui, Z. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2012.761245 · Cited by 32
Targeted Nanoparticulate drug-delivery Systems for Treatment of Solid Tumors: a Review
Bhattacharjee, H., Balabathula, P., & Wood, G. C. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.47 · Cited by 31
Inhalable materials and biologics for lung defence and drug delivery
Zhang, S., Edwards, D. A., Langer, R., & Cheng, K. (2025) · Nature Reviews Materials · doi:10.1038/s41578-025-00841-y · Cited by 46
Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems
Jiang, Sun, Yin, Y., Zhou, Ge, G., Liu, & Kong, F. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30928 · Cited by 29
Multifunctional composite capsules in drug delivery systems: bridging pharmaceutical and biomedical applications
Yu, Q., Tian, Z., Li, G., Yang, Y., Chen, X., Wang, D., Peng, W., Liu, R., Gu, H., & Yue, X. (2025) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-024-01203-y · Cited by 27
Mannosylated Polymeric Ligands for Targeted Delivery of Antibacterials and Their Adjuvants to Macrophages for the Enhancement of the Drug Efficiency
Zlotnikov, I. D., Ezhov, A. A., Petrov, R. A., Vigovskiy, M. A., Grigorieva, O., Belogurova, N. G., & Kudryashova, E. V. (2022) · Pharmaceuticals · doi:10.3390/ph15101172 · Cited by 27
Multifunctional nanoparticles for targeting cancer and inflammatory diseases
Jain, S., Doshi, A. S., Iyer, A. K., & Amiji, M. M. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.832769 · Cited by 27
Mannosylated Cationic Copolymers for Gene Delivery to Macrophages
Lopukhov, A. V., Zi-gang, Y., Haney, M. J., Bronich, T. K., Sokolsky‐Papkov, M., Batrakova, E. V., Klyachko, N. L., & Kabanov, A. V. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202000371 · Cited by 26
Mannosylated Systems for Targeted Delivery of Antibacterial Drugs to Activated Macrophages
Zlotnikov, I. D., Vigovskiy, M. A., Davydova, M. P., Danilov, M. R., Dyachkova, U., Grigorieva, O., & Kudryashova, E. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416144 · Cited by 30
Application Prospects of FTIR Spectroscopy and CLSM to Monitor the Drugs Interaction with Bacteria Cells Localized in Macrophages for Diagnosis and Treatment Control of Respiratory Diseases
Zlotnikov, I. D., Ezhov, A. A., Vigovskiy, M. A., Grigorieva, O., Dyachkova, U., Belogurova, N. G., & Kudryashova, E. V. (2023) · Diagnostics · doi:10.3390/diagnostics13040698 · Cited by 25
In Situ Reprogramming of Immune Cells Using Synthetic Nanomaterials
Nie, S., Qin, Y., Ou, L., Chen, X. S., & Li, L. (2024) · Advanced Materials · doi:10.1002/adma.202310168 · Cited by 25
Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers
Jin, Y., Wang, Y., Liu, X., Zhou, J., Wang, X., Feng, H., & Liu, H. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s260253 · Cited by 25
RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers
Magalhães, M., Alvarez‐Lorenzo, C., Concheiro, Á., Figueiras, A., Paiva‐Santos, A. C., & Veiga, F. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1517744 · Cited by 22
Solid lipid nanoparticles mediate non-viral delivery of plasmid DNA to dendritic cells
Penumarthi, A., Parashar, D., Abraham, A. N., Dekiwadia, C. D., Macreadie, I. G., Shukla, R., & Smooker, P. M. (2017) · Journal of Nanoparticle Research · doi:10.1007/s11051-017-3902-y · Cited by 24
Carbohydrate anchored lipid nanoparticles
Kakade, P., Chatterjee, A., Pandya, A., Disouza, J., & Patravale, V. B. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121681 · Cited by 23
Cervical Cancer Gene Therapy by Gene Loaded PEG-PLA Nanomedicine
Liu, B., Han, S., Tang, X., Han, L., & Li, C. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.12.4915 · Cited by 23
Long-term anesthetic analgesic effects: Comparison of tetracaine loaded polymeric nanoparticles, solid lipid nanoparticles, and nanostructured lipid carriers in vitro and in vivo
Liu, X., & Zhao, Q. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109057 · Cited by 23
Core-shell lipid polymer nanoparticles for combined chemo and gene therapy of childhood head and neck cancers
Zhang, T., Ma, J., Li, C., Lin, K. Y., Lou, F., Jiang, H., Gao, Y., Yang, Y., Ming, C., & Ruan, B. (2017) · Oncology Reports · doi:10.3892/or.2017.5365 · Cited by 22
Topical delivery of TRPsiRNA-loaded solid lipid nanoparticles confer reduced pain sensation via TRPV1 silencing, in rats
Sharma, G., Chopra, K., Puri, S., Bishnoi, M., Rishi, P., & Kaur, I. P. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1350857 · Cited by 23
Advances in therapeutic nanodrug delivery systems for infectious lung diseases: a review
Sheng, G., Tian, N., Duan, H., Sun, Z., & Chu, H. (2022) · Acta Materia Medica · doi:10.15212/amm-2022-0019 · Cited by 20
Infectious Diseases: Need for Targeted Drug Delivery
Devarajan, P. V., Dawre, S., & Dutta, R. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_3 · Cited by 21
Therapeutic potential of venom peptides: insights in the nanoparticle-mediated venom formulations
Joglekar, A. V., Dehari, D., Anjum, M. M., Kumar, D. N., Chaudhuri, A., Singh, S. K., & Agrawal, A. K. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00415-7 · Cited by 19
Mannan-Modified PLGA Nanoparticles for Targeted Gene Delivery
Kong, F., Ge, L., Liu, X., Huang, N., & Zhou, F. (2011) · International Journal of Photoenergy · doi:10.1155/2012/926754 · Cited by 18
Solid Lipid Nanoparticle-Based Drug Delivery for Lung Cancer
Abdelaziz, H. M., Freag, M. S., & Elzoghby, A. O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815720-6.00005-8 · Cited by 18
Mannose Receptor and Targeting Strategies
Jahagirdar, P. S., Lokhande, A. S., Dandekar, P. P., & Devarajan, P. V. (2019) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-29168-6_15 · Cited by 18
Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy
Chary, P. S., Shaikh, S., Rajana, N., Bhavana, V., & Mehra, N. K. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.213903 · Cited by 16
Pulmonary Drug Delivery System: A Novel Approach for Drug Delivery
Singh, A., Malviya, R., & Sharma, P. K. (2011) · Current Drug Therapy · doi:10.2174/157488511795304930 · Cited by 16
Glycosylated carriers for cell-selective and nuclear delivery of nucleic acids
Wijagkanalan, W. (2011) · Frontiers in bioscience · doi:10.2741/3892 · Cited by 17
Novel Mannan‐PEG‐PE Modified Bioadhesive PLGA Nanoparticles for Targeted Gene Delivery
Wu, G., Zhou, F., Ge, L., Liu, X., & Kong, F. (2012) · Journal of Nanomaterials · doi:10.1155/2012/981670 · Cited by 15
The Effect of White Light Spectrum Modifications by Excess of Blue Light on the Frost Tolerance, Lipid- and Hormone Composition of Barley in the Early Pre-Hardening Phase
Ahres, M., Pálmai, T., Kovács, T., Kovács, L., Lacek, J., Vaňková, R., Galiba, G., & Borbély, P. (2022) · Plants · doi:10.3390/plants12010040 · Cited by 14
Cell and organ drug targeting
Himri, I., & Guaâdaoui, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813665-2.00001-6 · Cited by 14
Studying The In Vitro Behavior of Cationic Solid Lipid Nanoparticles as A Nonviral Vector
Vighi, E., & Leo, E. (2011) · Nanomedicine · doi:10.2217/nnm.11.168 · Cited by 13
Facile synthesis of magnetic silica-mannan nanocomposites for enhancement in internalization and immune response of dendritic cells
Rodponthukwaji, K., Saengruengrit, C., Tummamunkong, P., Leelahavanichakul, A., Ritprajak, P., & Insin, N. (2021) · Materials Today Chemistry · doi:10.1016/j.mtchem.2020.100417 · Cited by 14
Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery
Jing, F., Li, D., Xu, W., Liu, Y., Wang, K., & Sui, Z. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2013.853812 · Cited by 13
Self-citation
Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome
Villa-Hermosilla, M.-C., Negro, S., Barcia, E., Hurtado, C., Montejo, C., Alonso, M., & Fernández-Carballido, A. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071392 · Cited by 13
Mannan as a Promising Bioactive Material for Drug Nanocarrier Systems
Yıldız, S. Y., & Öner, E. T. (2014) · InTech eBooks · doi:10.5772/58413 · Cited by 15

Authors: Yu, W., Liu, C., Liu, Y., Zhang, N., & Xu, W.
Affiliations: Shandong University (CN)
Corresponding author: Zhang, Na
ORCID: Liu, Chunxi
Liu, Yu
Zhang, Na
Xu, Wenfang
Venue: Pharmaceutical Research
Publisher: Springer Science and Business Media LLC
Published: 2010-04-27
Volume: 27
Issue: 8
Pages: 1584-1596
ISSN: 0724-8741 (ISSN-L)
1573-904X
DOI: 10.1007/s11095-010-0149-z
OpenAlex: W2008296427
Cited by: 137
References: 39
Citations by year: 2026: 1 · 2025: 3 · 2024: 7 · 2023: 8 · 2022: 15 · 2021: 9 · 2020: 14 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 11 · 2015: 10 · 2014: 10 · 2013: 7 · 2012: 9
FWCI: 3.64
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Pharmaceutical Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords: solid lipid nanoparticles, mannan, cationic liposomes, gene delivery, alveolar macrophages, targeted gene delivery, surface modification, DNA transfection, pulmonary gene delivery, RAW 264.7 macrophages
MeSH terms: Animals, Cell Line, Cell Survival, Concanavalin A, Ligands, Lipids, Male, Mannans, Phosphatidylethanolamines, Genetic Therapy, Molecular Structure, Drug Delivery Systems, Macrophages, Alveolar, Rats, Wistar, Cell Line, Tumor, Microscopy, Electron, Transmission, Mice, Rats, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks